Abstract
Dynamic membrane repair and remodelling is an elemental process that maintains cell integrity and mediates efficient cellular function. Here we report that MG53, a muscle-specific tripartite motif family protein (TRIM72), is a component of the sarcolemmal membrane-repair machinery. MG53 interacts with phosphatidylserine to associate with intracellular vesicles that traffic to and fuse with sarcolemmal membranes. Mice null for MG53 show progressive myopathy and reduced exercise capability, associated with defective membrane-repair capacity. Injury of the sarcolemmal membrane leads to entry of the extracellular oxidative environment and MG53 oligomerization, resulting in recruitment of MG53-containing vesicles to the injury site. After vesicle translocation, entry of extracellular Ca2+ facilitates vesicle fusion to reseal the membrane. Our data indicate that intracellular vesicle translocation and Ca2+-dependent membrane fusion are distinct steps involved in the repair of membrane damage and that MG53 may initiate the assembly of the membrane repair machinery in an oxidation-dependent manner.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Activation of SIRT1 promotes membrane resealing via cortactin
Scientific Reports Open Access 12 September 2022
-
The E3 ubiquitin ligase MG53 inhibits hepatocellular carcinoma by targeting RAC1 signaling
Oncogenesis Open Access 20 July 2022
-
Rosuvastatin exerts cardioprotective effect in lipopolysaccharide-mediated injury of cardiomyocytes in an MG53-dependent manner
BMC Cardiovascular Disorders Open Access 23 February 2022
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Get just this article for as long as you need it
$39.95
Prices may be subject to local taxes which are calculated during checkout








References
McNeil, P. L., Miyake, K. & Vogel, S. S. The endomembrane requirement for cell surface repair. Proc. Natl Acad. Sci. USA 100, 4592–4597 (2003).
Doherty, K. R. & McNally, E. M. Repairing the tears: dysferlin in muscle membrane repair. Trends Mol. Med. 9, 327–330 (2003).
Bansal, D. & Campbell, K. P. Dysferlin and the plasma membrane repair in muscular dystrophy. Trends Cell Biol. 14, 206–213 (2004).
Bazan, N. G., Marcheselli, V. L. & Cole-Edwards, K. Brain response to injury and neurodegeneration: endogenous neuroprotective signaling. Ann. NY Acad. Sci. 1053, 137–147 (2005).
McNeil, P. L. & Kirchhausen, T. An emergency response team for membrane repair. Nature Rev. Mol. Cell Biol. 6, 499–505 (2005).
Steinhardt, R. A., Bi, G. & Alderton, J. M. Cell membrane resealing by a vesicular mechanism similar to neurotransmitter release. Science 263, 390–393 (1994).
Miyake, K. & McNeil, P. L. Vesicle accumulation and exocytosis at sites of plasma membrane disruption. J. Cell Biol. 131, 1737–1745 (1995).
Bansal, D. et al. Defective membrane repair in dysferlin-deficient muscular dystrophy. Nature 423, 168–172 (2003).
Towler, M. C., Kaufman, S. J. & Brodsky, F. M. Membrane traffic in skeletal muscle. Traffic 5, 129–139 (2004).
Klinge, L. et al. From T-tubule to sarcolemma: damage-induced dysferlin translocation in early myogenesis. FASEB J. 21, 1768–1776 (2007).
Terasaki, M., Miyake, K. & McNeil, P. L. Large plasma membrane disruptions are rapidly resealed by Ca2+-dependent vesicle-vesicle fusion events. J. Cell Biol. 139, 63–74 (1997).
McNeil, P. L., Vogel, S. S., Miyake, K. & Terasaki, M. Patching plasma membrane disruptions with cytoplasmic membrane. J. Cell Sci. 113, 1891–1902 (2000).
Nishi, M. et al. Abnormal features in skeletal muscle from mice lacking mitsugumin29. J. Cell Biol. 147, 1473–1480 (1999).
Takeshima, H., Komazaki, S., Nishi, M., Iino, M. & Kangawa, K. Junctophilins: a novel family of junctional membrane complex proteins. Mol. Cell 6, 11–22 (2000).
Yazawa, M. et al. TRIC channels are essential for Ca2+ handling in intracellular stores. Nature 448, 78–82 (2007).
Weisleder, N., Takeshima, H. & Ma, J. Immuno-proteomic approach to excitation-contraction coupling in skeletal and cardiac muscle: molecular insights revealed by the mitsugumins. Cell Calcium 43, 1–8 (2008).
Reymond, A. et al. The tripartite motif family identifies cell compartments. EMBO J. 20, 2140–2151 (2001).
Meroni, G. & Diez-Roux, G. TRIM/RBCC, a novel class of 'single protein RING finger' E3 ubiquitin ligases. Bioessays 27, 1147–1157 (2005).
Ponting, C., Schultz, J. & Bork, P. SPRY domains in ryanodine receptors (Ca2+-release channels). Trends Biochem. Sci. 22, 193–194 (1997).
McNeil, P. L. & Khakee, R. Disruptions of muscle fiber plasma membranes. Role in exercise-induced damage. Am. J. Pathol. 140, 1097–1109 (1992).
Takekura, H., Fujinami, N., Nishizawa, T., Ogasawara, H. & Kasuga, N. Eccentric exercise-induced morphological changes in the membrane systems involved in excitation-contraction coupling in rat skeletal muscle. J. Physiol. 533, 571–583 (2001).
Coral-Vazquez, R. et al. Disruption of the sarcoglycan–sarcospan complex in vascular smooth muscle: a novel mechanism for cardiomyopathy and muscular dystrophy. Cell 98, 465–474 (1999).
Pan, Z. et al. Dysfunction of store-operated calcium channel in muscle cells lacking mg29. Nature Cell Biol. 4, 379–383 (2002).
Pouvreau, S. et al. Ca2+ sparks operated by membrane depolarization require isoform 3 ryanodine receptor channels in skeletal muscle. Proc. Natl Acad. Sci. USA 104, 5235–5240 (2007).
Dowler, S., Kular, G. & Alessi, D. R. Protein lipid overlay assay. Sci. STKE 2002, PL6 (2002).
Li, D., Miller, M. & Chantler, P. D. Association of a cellular myosin II with anionic phospholipids and the neuronal plasma membrane. Proc. Natl Acad. Sci. USA 91, 853–857 (1994).
Swairjo, M. A., Concha, N. O., Kaetzel, M. A., Dedman, J. R. & Seaton, B. A. Ca2+-bridging mechanism and phospholipid head group recognition in the membrane-binding protein annexin V. Nature Struct. Biol. 2, 968–974 (1995).
Dong, Z., Saikumar, P., Weinberg, J. M. & Venkatachalam, M. A. Calcium in cell injury and death. Annu. Rev. Pathol. 1, 405–434 (2006).
Han, R. & Campbell, K. P. Dysferlin and muscle membrane repair. Curr. Opin. Cell Biol. 19, 409–416 (2007).
Weiler, T. et al. Identical mutation in patients with limb girdle muscular dystrophy type 2B or Miyoshi myopathy suggests a role for modifier gene(s). Hum. Mol. Genet. 8, 871–877 (1999).
Saito, A. et al. Miyoshi myopathy patients with novel 5´ splicing donor site mutations showed different dysferlin immunostaining at the sarcolemma. Acta Neuropathol. 104, 615–620 (2002).
Glover, L. & Brown, R. H., Jr. Dysferlin in membrane trafficking and patch repair. Traffic 8, 785–794 (2007).
Weisleder, N. et al. Muscle aging is associated with compromised Ca2+ spark signaling and segregated intracellular Ca2+ release. J. Cell Biol. 174, 639–645 (2006).
Ko, J. K. & Ma, J. A rapid and efficient PCR-based mutagenesis method applicable to cell physiology study. Am. J. Physiol. Cell Physiol. 288, C1273–C1278 (2005).
Takeshima, H. et al. Excitation-contraction uncoupling and muscular degeneration in mice lacking functional skeletal muscle ryanodine-receptor gene. Nature 369, 556–559 (1994).
Yang, D. et al. RyR3 amplifies RyR1-mediated Ca2+-induced Ca2+ release in neonatal mammalian skeletal muscle. J. Biol. Chem. 276, 40210–40214 (2001).
Millay, D. P. et al. Genetic and pharmacologic inhibition of mitochondrial-dependent necrosis attenuates muscular dystrophy. Nature Med. 14, 442–447 (2008).
Acknowledgements
We thank Michael Reid, Jerome Parness, and Heping Cheng for helpful suggestions to this work. Yi Chu provided assistance in data processing and graphic conversions. We also thank the Cancer Institute of New Jersey Tissue Analytic Services Shared Resource and the UMDNJ-Cell Imaging Core facility, which is supported by NCRR from NIH, for providing assistance with imaging. This work was supported by grants from NIH (J.M.), Ministry of Education, Science, Sports and Culture of Japan (H.T.) and the American Heart Association (C.C., N.W., M.B.).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Information
Supplementary Information (PDF 1713 kb)
Supplementary Information
Supplementary Movie 1 (MOV 10189 kb)
Supplementary Information
Supplementary Movie 2 (AVI 3591 kb)
Supplementary Information
Supplementary Movie 3 (AVI 4216 kb)
Supplementary Information
Supplementary Movie 4 (AVI 9992 kb)
Supplementary Information
Supplementary Movie 5 (AVI 3781 kb)
Supplementary Information
Supplementary Movie 6 (MOV 2650 kb)
Supplementary Information
Supplementary Movie 7 (AVI 5766 kb)
Supplementary Information
Supplementary Movie 8 (AVI 4742 kb)
Supplementary Information
Supplementary Movie 9 (AVI 3589 kb)
Supplementary Information
Supplementary Movie 10 (AVI 3589 kb)
Supplementary Information
Supplementary Movie 11 (MOV 1543 kb)
Supplementary Information
Supplementary Movie 12 (MOV 1881 kb)
Rights and permissions
About this article
Cite this article
Cai, C., Masumiya, H., Weisleder, N. et al. MG53 nucleates assembly of cell membrane repair machinery. Nat Cell Biol 11, 56–64 (2009). https://doi.org/10.1038/ncb1812
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncb1812
This article is cited by
-
The cellular response to plasma membrane disruption for nanomaterial delivery
Nano Convergence (2022)
-
Rosuvastatin exerts cardioprotective effect in lipopolysaccharide-mediated injury of cardiomyocytes in an MG53-dependent manner
BMC Cardiovascular Disorders (2022)
-
The E3 ubiquitin ligase MG53 inhibits hepatocellular carcinoma by targeting RAC1 signaling
Oncogenesis (2022)
-
Activation of SIRT1 promotes membrane resealing via cortactin
Scientific Reports (2022)
-
Cardiac effects and clinical applications of MG53
Cell & Bioscience (2021)